Surge in Global Gamma Knife Industry Projected to Reach USD 702.5 Million by 2033 | FMI

The global gamma knife industry is set for substantial growth in the coming years, with market size projections reaching an impressive USD 702.5 million by 2033, up from USD 337.7 million in 2023. This surge represents a robust compound annual growth rate (CAGR) of 7.6% from 2023 to 2033.

This impressive growth trajectory is fueled by a combination of factors, including the expanding range of medical applications, favorable reimbursement policies, and the rapid development of healthcare infrastructure in emerging markets. The Gamma Knife, an advanced technology used primarily for treating brain disorders such as tumors and arteriovenous malformations, is gaining traction as its clinical applications broaden and more healthcare systems adopt this non-invasive treatment approach.

Gain Access to Market Trends: Request Your Sample Report! https://www.futuremarketinsights.com/report-sample#5245502d47422d353839

Key Drivers of Growth:

• Expanding Applications: The Gamma Knife’s evolving role in treating various neurological conditions beyond traditional uses is contributing to its growing adoption. Medical advancements continue to unlock new opportunities for this innovative treatment, further supporting market growth.
• Favorable Reimbursement Policies: Increased insurance coverage and reimbursement policies for Gamma Knife procedures are making it more accessible to a wider patient base, fostering market demand.
• Growth in Emerging Markets: Healthcare systems in developing regions are advancing rapidly, with an increased focus on adopting state-of-the-art medical technologies. The Gamma Knife’s non-invasive nature and effectiveness in treating complex neurological conditions are driving its adoption in these regions.

As the market for Gamma Knife continues to expand, stakeholders in the healthcare sector are keenly focused on leveraging this technology’s potential to improve patient outcomes and broaden access to cutting-edge treatments.

The global Gamma Knife industry promising outlook underpins its significant role in the ongoing evolution of healthcare, particularly in the treatment of neurological conditions, offering new hope to patients and advancing medical science.

Market Outlook:

The gamma knife market’s promising outlook is propelled by innovation and increasing demand for minimally invasive neurosurgical treatments. With the continued development of healthcare infrastructure and expanding applications, gamma knife technology is positioned as a critical tool in advanced neurological care.

Key Takeaways from the Market Study:

• Global gamma knife industry was valued at USD 313.8 million by 2022-end.
• From 2018 to 2022, the market demand expanded at a CAGR of 7.2%.
• The market in India is expected to expand at a CAGR of 11.4% through 2033.
• By disease, the brain metastases segment to account for a share of 69.2% in 2033.
• From 2023 to 2033, gamma knife market is expected to flourish at a CAGR of 7.6%.
• By 2033, the market value of gamma knife is expected to reach USD 702.5 million.

Gamma knife can complement regenerative medicine and stem cell therapies by providing a precise means of targeting specific areas in the brain for treatment, remarks an FMI analyst.

Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis! https://www.futuremarketinsights.com/reports/gamma-knife-market

Competitive Landscape:

Prominent players in the gamma knife industry are Elekta, Varian Medical Systems, Huiheng Medical, Inc., Akesis, Inc., MASEP Medical Science Technology Development (Shenzhen) Co., Ltd., American Radiosurgery Inc., Panacea Medical Technologies Pvt. Ltd., Nordion (Canada) Inc., Accuray Incorporated, and Hitachi, Ltd., among others.

Recent Developments:

• In 2023, Varian announced the launch of its new Varian gamma knife icon system. The system features a more compact design, improved image guidance, and a faster treatment delivery system.
• In 2022, Akesis announced the launch of its new Akesis Galaxy SRS system. The system is the first and only gamma knife system to use a linear accelerator instead of a cobalt 60 source.

Segmentation Analysis of the Gamma Knife Industry:

By Disease Indication:

• Brain Metastasis
• Cancer
• Arteriovenous Malformation
• Trigeminal Neuralgia
• Others

By Anatomy:

• Head
• Neck
• Other Body Parts

By Region:

• North America
• Latin America
• Western Europe
• Eastern Europe
• South Asia & Pacific
• East Asia
• The Middle East & Africa

Fuel Your Healthcare Business with Actionable Insights! https://www.futuremarketinsights.com/industry-analysis/radiation-therapy

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube